TransUnion (TRU)
Prix: 66.13Entreprise et modèle économique
TransUnion (TRU) is a global information and insights company that provides credit reporting, risk management, and fraud detection services. Its core products include credit reports, credit scores, and identity verification solutions. The company operates primarily in the financial services, healthcare, and retail sectors, generating revenue through subscription services, data analytics, and consulting. TransUnion's major business segments include U.S. Information Services, International, and Consumer Interactive.
Profil d’investissement
The investment profile of TransUnion is more aligned with balanced investors, given its moderate dividend yield and growth potential. The stock exhibits stable revenue growth, making it suitable for those seeking a combination of income and capital appreciation. The company's risk profile suggests a cautious approach, appealing to investors who prioritize stability over high volatility.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 3.64 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- 6.3% ↑
- Surprise BPA
- 6.3% meilleur que prévu
- Volatilité 20 j
- 2.5% stable
- Rendement du dividende
- 0.7% faible dernière date ex-dividende: 2026-05-27
Suivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-05 02:50 | Conserver | Vendre | Weak momentum and high risk limit upside potential. |
| 2026-05-28 03:34 | Vendre | Conserver | Positive revenue growth, but negative long-term momentum. |
| 2026-05-20 02:58 | Conserver | Vendre | Weak momentum and high risk overshadow potential upside. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-04-29 11:21 | Robert W. Baird | Objectif relevé | 107 → 108 | 70.08 |
| 2026-04-16 08:56 | Mizuho Securities | Mettre à jour | — → 80 | 74.81 |
| 2026-03-11 12:37 | New Street | Objectif abaissé | 105 → 100 | 71.61 |
Rien pour le moment